How many studies have been conducted on Serum Amyloid P Component?

BiohacksAI has indexed 300 PubMed studies on Serum Amyloid P Component, including 2 randomized controlled trials (RCTs). 24% of studies involve human subjects.

What are the main research areas for Serum Amyloid P Component?

The primary research domains for Serum Amyloid P Component are 🧠 Neuroprotection, 🔬 Inflammation, 🦴 Bone & Joint. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Serum Amyloid P Component

a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE.

300+ PubMed studies analyzed · 2 RCTs · Evidence Score: 44.7

Research Domains

Serum Amyloid P Component has been studied across 18 research domains including 🧠 Neuroprotection, 🔬 Inflammation, 🦴 Bone & Joint, ⏳ Longevity & Aging, 🫁 Liver & Detox. The primary research focus is 🧠 Neuroprotection with 99% of studies addressing this area.

Loading evidence profile...

This evidence profile for Serum Amyloid P Component is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.